Author | Jared Kaltwasser


Is the Biosimilars Waiting Game Finally Over?

July 30, 2020


Advocates say a number of regulatory changes could help bring more of these products on to the market.

Key Events Drive Significant Portion of Association Between Depression, Healthcare Utilization and Cost

July 17, 2020


Patients with major depressive disorder have higher healthcare utilization rates when they experience certain key clinical events, according to a new study.

Do DMTs Increase the Risk of COVID-19 for MS Patients?

July 13, 2020


Are patients with MS taking DMTs at higher risk of infection or case severity during COVID-19? A small study suggests that may not the case with one.

Boosting Molecular Testing in Patients with GIST Would Have Minimal Cost Impact, Study Finds

July 06, 2020


Researchers cost-impact model calculates the cost to be 15 centers PMPY.